Prenetics Global PRE
NASDAQ PRE
$17.32 -0.23 (-1.34%)
As of: Nov 10, 2026 · 12:51 PM EST

Prenetics Global (PRE) Cash from Restructuring (2022)

Updated

Prenetics Global (PRE) recorded Cash from Restructuring of $2.71 million in Q4 2022, down 90.2% from the prior quarter.

Analysis

Prenetics Global (PRE) Cash from Restructuring (2022) Analysis & Trends

For FY2022, Prenetics Global reported Cash from Restructuring of $30.38 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn
10 Prenetics Global 251.88 Mn -36.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.71 Mn
Sep 30, 2022 27.67 Mn
API Access

Prenetics Global Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=PRE&period=max&api_key=YOUR_API_KEY